PRKR News Alert Parkervision (PRKR) 1.07 02/13/2015 22:14:47

New Post Public Reply Private Reply Replies (0) Message Board

Feb 13, 2015 at 11:14 PM

Parkervision (PRKR) 1.07 $PRKR

Congress takes another stab at patent law reform
Seeking Alpha - at Seeking Alpha - Sun Feb 08, 2:32PM CST

VRNG: 0.81 (+0.01), WILN: 2.71 (-0.01), ACTG: 13.13 (+0.04), PRKR: 1.07 (+0.04), MARA: 6.67 (-0.04), FNJN: 2.77 (-0.36), DSS: 0.43 (+0.03), SPEX: 0.98 (-0.01), VHC: 5.53 (+0.09)

It's A MARA-Thon, Not A Sprint In The Patent Monetization Space
IP Hawk - at Seeking Alpha - Thu Jan 29, 7:42AM CST

VRNG: 0.81 (+0.01), MARA: 6.67 (-0.04), PRKR: 1.07 (+0.04), SPEX: 0.98 (-0.01), DSS: 0.43 (+0.03), VHC: 5.53 (+0.09)

Patent stocks rally after Supreme Court's Teva ruling
Seeking Alpha - at Seeking Alpha - Tue Jan 20, 1:15PM CST

WILN: 2.71 (-0.01), PRKR: 1.07 (+0.04), FNJN: 2.77 (-0.36), SPEX: 0.98 (-0.01)

ParkerVision Closes Previously Announced Sale of Warrants
GlobeNewswire - Fri Jan 16, 5:59AM CST
ParkerVision, Inc. (Nasdaq

RKR) ("ParkerVision"

announced the closing on January 15, 2015 of its previously announced sale of warrants to 1624 PV LLC for an aggregate purchase price of $1,300,000. ParkerVision issued three warrants, each exercisable for up to 1,884,058 shares of common stock at exercise prices of $1.50, $2.50 and $3.50 per share, respectively. The warrants are exercisable for a period of three years from the date of issuance.
PRKR: 1.07 (+0.04)

ParkerVision up strongly after IPR petition denied
Seeking Alpha - at Seeking Alpha - Thu Jan 08, 2:10PM CST

PRKR: 1.07 (+0.04)

Patent Trial and Appeal Board Denies IPR Petition Aimed at ParkerVision '342 Patent
GlobeNewswire - Thu Jan 08, 12:26PM CST
ParkerVision, Inc. (Nasdaq

RKR), a developer and marketer of semiconductor technology solutions for wireless applications, today announced that on January 8, 2015, the Patent Trial and Appeal Board ("PTAB"

denied institution of trial of all challenged claims for Inter Partes review ("IPR"

of ParkerVision patent 7,496,342 ("the '342 patent"

. The IPR petition was filed in July, 2014 by RPX Corporation and Michael Farmwald against five claims of the '342 patent. The '342 patent is one of the four patents subject to ParkerVision's pending appeal in its patent infringement case against Qualcomm, Incorporated.
QCOM: 70.88 (+0.49), PRKR: 1.07 (+0.04)

Turnaround potential? 2014's worst performers in the Russell 2000
Seeking Alpha - at Seeking Alpha - Sun Jan 04, 2:49PM CST

KWK: 0.15 (unch), BPZ: 0.25 (unch), EXXI: 4.00 (+0.42), MBII: 3.88 (+0.33), MILL: 2.07 (+0.09), PHMD: 1.68 (+0.04), PRKR: 1.07 (+0.04), RLOC: 3.58 (+0.42), NTLS: 5.19 (+0.05), VTG: 0.52 (-0.02), GDP: 3.58 (+0.29), REN: 1.14 (unch), CYTX: 0.47 (unch), XONE: 16.93 (-0.16), KEG: 2.14 (+0.08), REXX: 5.08 (+0.13), AMZG: 0.65 (-0.03), COVS: 2.47 (+0.11), EXEL: 2.48 (+0.20), ANV: 0.97 (-0.03), VRNG: 0.81 (+0.01), FUEL: 14.30 (+0.65), ZQK: 2.26 (+0.05), GALT: 3.84 (+0.16), EOX: 1.15 (unch), SALT: 2.17 (+0.18), MM: 1.67 (+0.07), WLT: 1.09 (+0.05), NADL: 2.10 (-0.02), QRHC: 1.30 (+0.03), MCP: 0.97 (+0.04), ANR: 1.27 (+0.03), ARO: 3.63 (+0.04), RGDO: 1.17 (+0.02), HERO: 0.92 (+0.02), FWM: 5.55 (+0.08), CONN: 24.69 (-0.07), MPO: 1.00 (-0.02), CVEO: 3.87 (+0.15), SZYM: 2.64 (+0.02)

Stock to Watch: Parkervision Up 15.5% (PRKR)
Comtex SmarTrend(R) - Wed Dec 24, 11:34AM CST
Parkervision (NASDAQ

RKR) is one of today's best performing penny stocks, up 15.5% to $0.99 on 1.1x average daily volume. Parkervision has traded 832,000 shares thus far today, vs. average volume of 738,000 shares per day. The stock has outperformed the Dow (15.1% to the Dow's 0.3%) and outperformed the S&P 500 (15.1% to the S&P's 0.2%) during today's trading.
PRKR: 1.07 (+0.04)

ParkerVision obtains up to $7M in legal funding
Seeking Alpha - at Seeking Alpha - Tue Dec 23, 3:59PM CST

PRKR: 1.07 (+0.04)

ParkerVision Receives $7 Million Litigation Funding Commitment
GlobeNewswire - Tue Dec 23, 3:05PM CST
ParkerVision, Inc. (Nasdaq

RKR), a developer, manufacturer and marketer of semiconductor technology solutions for wireless applications, announced today that it has entered into a Funding Agreement with 1624 PV, LLC, a litigation investment firm, (the "Funder"

for the funding of up to $7 million in legal fees and expenses for future patent infringement litigation to be brought by ParkerVision (the "Company"

. Under the terms of the agreement, the Company will reimburse and compensate the Funder from gross proceeds resulting from the funded legal actions up to a maximum amount (the "Cap"

, which is determined as a multiple of the funds disbursed by the Funder. The Funder may also receive a portion of gross proceeds from the Company's other patent litigation and patent-related monetization activities, subject to the Cap. The Funder has no security interest in any assets of the Company.
PRKR: 1.07 (+0.04)

ParkerVision to face IPR trials for 14 patent claims
Seeking Alpha - at Seeking Alpha - Thu Dec 18, 5:49PM CST

PRKR: 1.07 (+0.04)

PTAB Issues Mixed Decision on IPR Petitions for Three ParkerVision Patents
GlobeNewswire - Thu Dec 18, 3:37PM CST
ParkerVision, Inc. (Nasdaq

RKR), a developer and marketer of semiconductor technology solutions for wireless applications, today announced that the Patent Trial and Appeal Board ("PTAB"

of the United States Patent and Trademark Office ("USPTO"

denied institution of trial for inter partes review ("IPR"

of one claim contained in three ParkerVision patents and granted trial for 14 claims contained in those same three patents. The three IPR petitions were filed in June 2014 by RPX Corporation and Michael Farmwald against an aggregate of 15 patent claims of ParkerVision patents 6,601,551, 6,266,518 and 6,370,371. Ten claims from these same patents, including the one claim that was not instituted for inter partes review trial, are the subject of ParkerVision's pending appeal at the U.S. Court of Appeals for the Federal Circuit ("Federal Circuit"

in its patent infringement case against Qualcomm, Incorporated. The PTAB is expected to issue in early January 2015 a trial institution decision on a fourth IPR petition filed by the same parties against ParkerVision U.S. patent 7,496,342.
QCOM: 70.88 (+0.49), PRKR: 1.07 (+0.04)

Investors look to Lighten Up on Shares of Parkervision, Shares Down 6.1% (PRKR)
Comtex SmarTrend(R) - Thu Dec 04, 11:36AM CST
Parkervision (NASDAQ

RKR) is one of today's worst performing penny stocks, down 6.1% to $0.83 on 1.2x average daily volume. Thus far today, Parkervision has traded 602,000 shares, vs. average volume of 518,000 shares per day. The stock has underperformed the Dow (-5.8% to the Dow's -0.1%) and underperformed the S&P 500 (-5.8% to the S&P's -0.1%) during today's trading.
PRKR: 1.07 (+0.04)

ParkerVision Included in NYSE-Listed Ocean Tomo 300(R) Patent Index
GlobeNewswire - Wed Nov 12, 7:00AM CST
ParkerVision, Inc. (Nasdaq

RKR), a developer and marketer of semiconductor technology solutions for wireless applications, announced today its inclusion in the Ocean Tomo 300(R) Patent Index (NYSE:OTPAT) for 2014-2015. This Index is priced and published by the NYSE Euronext.
PRKR: 1.07 (+0.04)

ParkerVision -12.3% after reporting Q3 legal expense growth
Seeking Alpha - at Seeking Alpha - Tue Nov 11, 12:22PM CST

PRKR: 1.07 (+0.04)

Midday gainers / Losers
Seeking Alpha - at Seeking Alpha - Tue Nov 11, 11:45AM CST

FSM: 4.56 (+0.03), HEAR: 2.54 (-0.14), JRJC: 5.46 (+0.16), CVO: 1.92 (-0.04), AAOI: 10.15 (-0.05), UNIS: 4.32 (+0.06), HIIQ: 8.03 (+0.16), CYAN: 8.72 (+0.13), PTX: 8.63 (+0.01), TRMR: 2.15 (+0.04), PRKR: 1.07 (+0.04), SUMR: 2.91 (+0.02), VSLR: 8.39 (+0.06), RVP: 5.14 (-0.42), ASCMA: 47.45 (+0.25), ICUI: 88.98 (+0.42), CALL: 7.74 (+0.02), DMD: 5.13 (+0.10), AST: 3.85 (+0.13), ASEI: 56.82 (+0.30)

Parkervision Down 13.1%, Shares Slide into the Red (PRKR)
Comtex SmarTrend(R) - Tue Nov 11, 11:36AM CST
Parkervision (NASDAQ

RKR) is one of today's worst performing low-priced stocks, down 13.1% to $1.06 on 1.4x average daily volume. Thus far today, Parkervision has traded 518,000 shares, vs. average volume of 359,000 shares per day. The stock has underperformed the Dow (-13.1% to the Dow's -0.1%) and underperformed the S&P 500 (-13.1% to the S&P's -0.0%) during today's trading.
PRKR: 1.07 (+0.04)

ParkerVision's (PRKR) CEO Jeffrey Parker on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Mon Nov 10, 9:13PM CST

PRKR: 1.07 (+0.04)

ParkerVision Reports Third Quarter 2014 Results
GlobeNewswire - Mon Nov 10, 3:11PM CST
ParkerVision, Inc. (Nasdaq

RKR), a developer and marketer of semiconductor technology solutions for wireless applications, today announced results for the three and nine months ended September 30, 2014.
PRKR: 1.07 (+0.04)

ParkerVision misses by $0.06
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 3:03PM CST

PRKR: 1.07 (+0.04)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

New CEO at Simpli.fi: Sean McCaffrey Takes Charge

A New Captain at Simpli.fi's Helm In the fast-paced world of digital advertising, Simpli.fi isn't just sitting on the sidelines. They've gone and snagged Sean McCaffrey as their new CEO. Now, for those who remember GSTV's rise to 30,000 locations under McCaffrey, this appointment carries some serious weight. McCaffrey's Track Record: Setting the Pace McCaffrey's no...

Security Leadership Faces Unseen Identity Risks

Rocky Road in Identity Security Catch this: you're a security honcho, thinking you've forked over enough dough to lock down human and machine identities. But now, it turns out, most of your kind still don't have a full handle on who or what is poking around your systems. Talk about a wrench in the gears. This latest report from Oak drags the reality into the limelight:...

Roof Inspections: Richmond's Key to Home Longevity

Inspect, Protect, and Forget Your Worries Homeowners in the Greater Richmond area wisely take to heart the old saying: an ounce of prevention is worth a pound of cure. But let's cut through the noise for a moment and zero in on a foundational truth: regular roof inspections are not a luxury—they're an absolute must. Roofing expert Seth Brown, from BNH Roofing, makes it...

OppFi Readies Q3 Earnings; Investors Eye Financials

What's Unfolding at OppFi? Mark your calendars, folks. October 28th is the day OppFi (NYSE: OPFI) pulls the curtain back on its third-quarter 2026 earnings. For the uninitiated, we're talking about a tech-driven finance platform that's been making waves by providing financial solutions for everyday Americans. And you bet we're all ears for what those numbers say. Details...

King City Gardens Debuts Third Dispensary in Cincinnati

Every corner of Cincinnati’s cannabis scene just got a little busier with King City Gardens opening up shop in Colerain Township. This move marks their third Garden Dispensary in Greater Cincinnati. It’s not just about adding another location, though. It’s King City’s way of cementing their local roots deeper into the city’s soil, rolling out a mix of...

Teen Driver Safety Week: Practical Tips for Parents

The Growing Pains of Teen Driving Getting a driver's license is exciting for teens, but let's face it—the road is no playground. In 2024, a staggering 2,320 lives were lost in the U.S. due to crashes with teen drivers at the wheel. These stats aren’t just numbers—they’re grim reminders that safety isn’t a given for young drivers. Amidst this backdrop, the...

Netcapital Faces Securities Fraud Claims: Key Investor Notes

Netcapital Under Fire: The Suit Unfolds You ever see a stock go through such highs and lows that you wish you had popcorn on standby? Well, that's where Netcapital Inc. (NASDAQ: NCPL) is sitting right now, in the midst of a class action lawsuit that's got investors' heads spinning. The accusations are serious: false and misleading statements about revenues that seem to...

Tenet® Beef: Revolutionizing Tenderness in America's Steaks

Cracking the Code: A Genetic Leap in Beef Tenderness Well, buckle up, folks, because Callipyge Genetics is shaking things up in the beef aisle with their genomic breakthrough, Tenet®. It's about time we see some real innovation in an industry that's, let's face it, been slow to evolve. This isn't just a flash in the pan—a bit of DNA parsing has uncovered how to...

Nest Health Appoints Peter Morrison for Multistate Expansion

Peter Morrison Steps Up as Chief Growth Officer You know, it's not every day you see a move as gutsy as Nest Health's recent appointment of Peter Morrison. They're shaking up the Medicaid space, aiming to redefine primary care for families with limited resources. Morrison, coming from heavyweights like UnitedHealthcare and Centene, isn't your typical pencil-pusher. He’s...

LBT Unveils Game-Changing Cyclotron for Medical Advances

Unveiling the LB-30 Cyclotron at EANM 2026 Life in nuclear medicine never stands still, and once again, Longevous Beamtech (LBT) is stirring the pot with its brand-new LB-30 series medical cyclotron. They rolled out this high-powered beast at the 39th Annual Congress of the European Association of Nuclear Medicine (EANM 2026) in Vienna. Leaning into the 30 MeV energy...